OWCP (OWC Pharmaceutical Research) Market Cap: $0.00 Mil (As of Jun. 25, 2026)


What is OWC Pharmaceutical Research Market Cap?

OWC Pharmaceutical Research OWCP -90.00% Market Cap is $0.00 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OWC Pharmaceutical Research's share price for the quarter that ended in Sep. 2019 was $0.0103. OWC Pharmaceutical Research's Shares Outstanding (EOP) for the quarter that ended in Sep. 2019 was 244.48 Mil. Therefore, OWC Pharmaceutical Research's market cap for the quarter that ended in Sep. 2019 was $2.52 Mil.

OWC Pharmaceutical Research's quarterly market cap declined from Mar. 2019 ($5.98 Mil) to Jun. 2019 ($3.51 Mil) and declined from Jun. 2019 ($3.51 Mil) to Sep. 2019 ($2.52 Mil).

OWC Pharmaceutical Research's annual market cap increased from Dec. 2016 ($24.54 Mil) to Dec. 2017 ($67.17 Mil) but then declined from Dec. 2017 ($67.17 Mil) to Dec. 2018 ($15.55 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OWC Pharmaceutical Research's Enterprise Value for Today is $0.00 Mil.

OWC Pharmaceutical Research  (OTCPK:OWCP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

OWC Pharmaceutical Research Market Cap Related Terms

OWC Pharmaceutical Research Market Cap Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research Market Cap Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Market Cap
Get a 7-Day Free Trial Premium Member Only 15.06 2.44 24.54 67.17 15.55

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.53 15.55 5.98 3.51 2.52

OWCP vs PARNF, CANB, CXUS: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OWC Pharmaceutical Research Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's Market Cap distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's Market Cap falls into.


OWC Pharmaceutical Research Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

OWC Pharmaceutical Research's Market Cap for the fiscal year that ended in Dec. 2018 is calculated as

Market Cap (A: Dec. 2018 )=Share Price (A: Dec. 2018 )*Shares Outstanding (EOP) (A: Dec. 2018 )
=$0.1035*150.207
=$15.55

OWC Pharmaceutical Research's Market Cap for the quarter that ended in Sep. 2019 is calculated as

Market Cap (Q: Sep. 2019 )=Share Price (Q: Sep. 2019 )*Shares Outstanding (EOP) (Q: Sep. 2019 )
=$0.0103*244.478
=$2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
OWC Pharmaceutical Research (OWCP) has a Market Cap of $0.00 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's Market Cap too high?
OWC Pharmaceutical Research's current Market Cap is $0.00 Mil.
How does OWC Pharmaceutical Research's Market Cap compare to PARNF and CANB?
OWC Pharmaceutical Research's Market Cap of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 206.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.50, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OWC Pharmaceutical Research and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OWC Pharmaceutical Research's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current Market Cap is $0.00 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.